Melanoma, a skin cancer associated with high mortality rates, is highly radio-and
chemotherapy resistant but can also be very immunogenic. These circumstances have led to …

Objective To evaluate rates of serious organ specific immune-related adverse events,
general adverse events related to immune activation, and adverse events consistent with …

Head and neck cancers, including those of the lip and oral cavity, nasal cavity, paranasal
sinuses, oropharynx, larynx and nasopharynx represent nearly 700,000 new cases and …

In the past decades, our knowledge about the relationship between cancer and the immune
system has increased considerably. Recent years' success of cancer immunotherapy …

The approval of immunotherapeutic agents and immunotherapy-based combination
strategies in recent years has revolutionized the treatment of patients with advanced renal …

Abstract Background/objectives Acute Kidney Injury (AKI), induced by Checkpoint Inhibitors
therapies (CPI-induced AKI), is an uncommon but severe Immune-Related Adverse Event …

Introduction: Immune-related ocular toxicities are uncommon but serious adverse events that
may be associated with the use of immune checkpoint inhibitors. The objective of this review …

Checkpoint inhibitors have revolutionized the treatment of patients with metastatic
melanoma offering improved responses and significant survival benefit. These agents are …

Immune checkpoint inhibitors (ICIs) are specialized monoclonal antibodies (mAbs) that
target immune checkpoints and their ligands, counteracting cancer cell-induced T-cell …

Abstract Background: Immune checkpoint inhibitors (ICIs) emerged as the preferred therapy
in advanced lung cancer, understanding the treatment-and immune-related adverse events …